Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pavmed Inc 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 USA

www.pavmed.com Employees: 39 P: 917-813-1828

Sector:

Medical

Description:

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 9,985
Enterprise Value, $K 33,125
Shares Outstanding, K 984
Float, K 927
% Float 94.20%
Short Interest, K 23
Short Float 2.37%
Days to Cover 1.11
Short Volume Ratio 0.46
% of Insider Shareholders 5.80%
% of Institutional Shareholders 19.93%

Financials:

Annual Sales, $ 70 K
Annual Net Income, $ 400 K
Last Quarter Sales, $ 50 K
Last Quarter Net Income, $ -1,260 K
EBIT, $ -21,810 K
EBITDA, $ -21,700 K

Growth:

1-Year Return -53.64%
3-Year Return -93.84%
5-Year Return -99.62%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -8.41 on 11/13/25
Next Earnings Date 05/21/26
Earnings Per Share ttm -14.71
EPS Growth vs. Prev Qtr 84.96%
EPS Growth vs. Prev Year 66.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 01/02/26

PAVM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -242.99%
Return-on-Assets % -17.25%
Profit Margin % 571.43%
Debt/Equity 0.00
Price/Sales 135.79
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 22.76
Interest Coverage -122.50
60-Month Beta 0.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.